Caxton Corporation’s Aclaris Therapeutics ACRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
|
|||||
|
2023
Q3 | $133K | Buy |
|
|||||
|
2019
Q1 | – | Sell |
|
|||||
|
2018
Q4 | $453K | Buy |
|
|||||
|
2018
Q3 | $577K | Buy |
|
|||||
|
2018
Q2 | $390K | Sell |
|
|||||
|
2018
Q1 | $370K | Buy |
|
|||||
|
2017
Q4 | $444K | Buy |
|
|||||
|
2017
Q3 | $263K | Buy |
|
|||||
|
2017
Q2 | $275K | Sell |
|
|||||
|
2017
Q1 | $395K | Buy |
|
|||||
|
2016
Q4 | $359K | Buy |
|